Narrow search
Showing 1 - 10 of 389
Cover Image
Private versus social incentives for pharmaceutical innovation
González, Paula; Macho-Stadler, Inés; … - 2015
We provide a theoretical framework to contribute to the current debate regarding the tendency of pharmaceutical companies to direct their R&D toward marketing products that are "follow-on" drugs of already existing drugs, rather than toward the development of breakthrough drugs. We construct a...
Persistent link: https://www.econbiz.de/10011406575
Cover Image
The impact of R&D cooperations on drug variety offered on the market : evidence from the pharmaceutical industry
Banerjee, Tannista; Siebert, Ralph - 2014
Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...
Persistent link: https://www.econbiz.de/10010229875
Cover Image
Dynamic mergers effects on R&D investments and drug development across research phases in the pharmaceutical industry
Siebert, Ralph; Tian, Zhili - 2020
Pharmaceutical firms spend increasing amounts in mergers and acquisitions (M&As), which raises the question of whether sufficient investment is left after mergers to further develop firms' internal drug development capability. We evaluate the effects of M&As on firms' post-merger R&D...
Persistent link: https://www.econbiz.de/10012219372
Cover Image
The effect of intellectual property rights on domestic innovation in the pharmaceutical sector
Gamba, Simona - 2016
This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of …. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for … to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries …
Persistent link: https://www.econbiz.de/10011509446
Cover Image
Pharmaceutical innovation, longevity, and medical expenditure in Greece, 1995 - 2010
Lichtenberg, Frank - 2015
Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months) - about 44% of the total increase in longevity … pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …
Persistent link: https://www.econbiz.de/10010473542
Cover Image
Dynamic effects of licensing and knowledge transfer across research stages : evidence from the pharmaceutical industry
Tian, Zhili; Siebert, Ralph - 2020
In the pharmaceutical industry, firms frequently engage in licensing agreements to overcome innovation challenges and …
Persistent link: https://www.econbiz.de/10012219514
Cover Image
Medical innovations and ageing : a health economics perspective
Grossmann, Volker - 2021
surveys empirical evidence on medical R&D incentives, R&D costs of pharmaceuticals, and the cost-effectiveness of health …
Persistent link: https://www.econbiz.de/10012653346
Cover Image
Is medicines parallel trade "regulatory arbitrage"?
Costa-Font, Joan - 2015
In the European Union, medicines are regulated products subject to both single market (e.g., regional exhaustion of property rights) and country specific health care regulations (e.g., medicines pricing). This gives rise to parallel trade (PT), a phenomenon that takes place when a patented...
Persistent link: https://www.econbiz.de/10010477153
Cover Image
Pharmaceutical prices : the impact of the launch strategy - an analysis of German data
Böhler, Yvonne-Beatrice; Lamping, Christian; Wichardt, … - 2019 - This Version: September 24, 2019
pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …
Persistent link: https://www.econbiz.de/10012119750
Cover Image
How trust in social dilemmas evolves with age
Kocher, Martin - 2015
While trust and trustworthiness provide a fundamental foundation for human relationships, little is known about how trusting and trustworthy behavior in social dilemmas is related to age and aging. A few papers use data from surveys such as the World Values Survey to address a potential...
Persistent link: https://www.econbiz.de/10011298524